Source: http://www.annalsofhealthlaw.com/annalsofhealthlaw/vol_22_issue_1?pg=11
Timestamp: 2019-04-19 23:12:38+00:00

Document:
sperm donors, their application in the Arsenault case, and the implications of expanding the government’s regulatory authority over individuals’ procreative decisions. Part I describes the phenomenon of private sperm donation and how it fits into the landscape of reproductive medicine. Part II discusses federal statutes and regulations that have historically been enforced against medical establishments involved with sperm donation. Part III discusses the Arsenault case and the FDA’s unprecedented decision to enforce these regulations against a private sperm donor. Part IV examines whether the regulations and their enabling statute, in fact, cover private sperm donor activity. Part V analyzes the possible consequences of expanded federal regulatory authority over private, individual-to-individual donations of sperm for artificial insemination.
17. 21 C.F.R § 1271.1 (2012); 21 C.F.R § 1271.170 (2012).
18. LOUISE SLOAN, KNOCK YOURSELF UP: NO MAN? NO PROBLEM! : A TELL-ALL GUIDE TO BECOMING A SINGLE MOM (2007).
19. 21 C.F.R § 1271.50 (2005); 21 C.F.R. § 1271.75 (2005); 21 C.F.R. § 1271.80 (2005); 21 C.F.R. § 1271.85 (2005).
20. SLOAN, supra note 18, at 67.
21. 21 C.F.R § 1271.60 (2012); 21 C.F.R. § 1271.85(d) (2012). Indeed, the six-month quarantine period is mandated by the FDA’s regulations governing HCT/P’s.

References: § 1271
 § 1271
 § 1271
 § 1271
 § 1271
 § 1271
 § 1271
 § 1271